Galleria mellonella in vitro model for chromoblastomycosis shows large differences in virulence between isolates

Dongmei Shi1,2, Zhiya Yang2, Wanqing Liao3

  • 1Department of Dermatology & Laboratory of Medical Mycology, Jining No. 1 People's Hospital, Shandong, China.

IMA Fungus
|March 8, 2024
PubMed
Abstract

Insights

This study reveals that Cladophialophora carrionii strains vary in their ability to cause chromoblastomycosis (fungal disease) in Galleria mellonella larvae, with some antifungals showing better efficacy than others.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Antimicrobial Research

Background:

  • Chromoblastomycosis is a WHO-recognized fungal disease causing severe mutilation.
  • Cladophialophora carrionii is a causative agent, but its pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the pathogenic potential of Cladophialophora carrionii strains.
  • To evaluate the in vivo efficacy of several antifungal agents against Cladophialophora species.

Main Methods:

  • Utilized a Galleria mellonella larvae infection model to assess fungal pathogenicity.
  • Tested six strains of Cladophialophora carrionii and three of Cladophialophora yegresii.
  • Determined antifungal efficacy of amphotericin B, itraconazole, voriconazole, posaconazole, and terbinafine.

Main Results:

  • All tested Cladophialophora strains infected Galleria mellonella larvae, with strain-specific virulence.
  • Larval survival depended on infection dose, fungal growth rate, and melanization.
  • Posaconazole and voriconazole demonstrated the highest antifungal activity in vivo.

Conclusions:

  • Infection behavior varies significantly among Cladophialophora strains.
  • In vitro antifungal susceptibility partially explains in vivo treatment efficacy limitations.

Related Concept Videos